BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6039533)

  • 1. [Atromid].
    Borchgrevink CF
    Tidsskr Nor Laegeforen; 1967 Mar; 87(5):334. PubMed ID: 6039533
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of Atromid on blood lipids in patients with hyperlipemia].
    Baranova LV
    Ter Arkh; 1968 Mar; 40(3):15-20. PubMed ID: 4875984
    [No Abstract]   [Full Text] [Related]  

  • 3. Atromid-S for the reduction of plasma lipids.
    Med Lett Drugs Ther; 1967 Jun; 9(12):45-7. PubMed ID: 6037633
    [No Abstract]   [Full Text] [Related]  

  • 4. A controlled trial of Atromid therapy in exudative diabetic retinopathy.
    Cullen JF; Ireland JT; Oliver MF
    Trans Ophthalmol Soc U K (1962); 1964; 84():281-95. PubMed ID: 5227423
    [No Abstract]   [Full Text] [Related]  

  • 5. Atromid and platelet adhesiveness in multiple sclerosis.
    Millac P; Caspary EA; Prineas J
    J Atheroscler Res; 1967; 7(3):397-400. PubMed ID: 5340971
    [No Abstract]   [Full Text] [Related]  

  • 6. Communications. Action of Atromid-S (clofibrate) on intra-ocular pressure.
    Gloster J; Hartley RE; Perkins ES
    Br J Ophthalmol; 1968 Nov; 52(11):793-800. PubMed ID: 4972749
    [No Abstract]   [Full Text] [Related]  

  • 7. A three-year trial of atromid therapy in exudative diabetic retinopathy.
    Duncan LJ; Cullen JF; Ireland JT; Nolan J; Clarke BF; Oliver MF
    Diabetes; 1968 Jul; 17(7):458-67. PubMed ID: 4875170
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of platelet stickiness tests during an atromid-S trial.
    O'Brien JR; Heywood JB
    Thromb Diath Haemorrh; 1966 Dec; 16(3):768-77. PubMed ID: 5996687
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of hyperlipidemia with the ethyl-ester of chlorophenoxyisobutyrate and androsterone.
    Schatz IJ
    Henry Ford Hosp Med J; 1965 Dec; 13(4):447-56. PubMed ID: 5325188
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypolipidemic agents--newly approved.
    Duncan GG
    Pa Med; 1967 Aug; 70(8):75-6. PubMed ID: 6073724
    [No Abstract]   [Full Text] [Related]  

  • 11. Trial of "Atheran" and "Atromid-S" in atherosclerosis.
    Barnett AJ; Carson V
    Med J Aust; 1966 Jun; 1(23):965-70. PubMed ID: 5939995
    [No Abstract]   [Full Text] [Related]  

  • 12. [CPIB: a hypolipidemic agent. Study of 20 patients].
    Verdy M
    Union Med Can; 1966 Sep; 95(9):1049-52. PubMed ID: 5913817
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experience with 110 medium-length therapeutic trials of ethyl chlorophenoxyisobutyrate with or without androsterone in various types of idiopathic hyperlipidemia].
    De Gennes JL; Maunand B; Salmon D; Laudat P; Truffert J
    Rev Atheroscler (Paris); 1966; 8(1):27-52. PubMed ID: 5961027
    [No Abstract]   [Full Text] [Related]  

  • 14. [Action mechanism and clinical success of Regelan (Clofibrate)].
    Fitzgerald JD
    Wien Klin Wochenschr; 1967 Sep; 79(39):716-20. PubMed ID: 5595437
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experimentation with CPIB (with or without androsterone) in the treatment of hyperlipemia. Apropos of 35 cases].
    Warembourg H; Jaillard J
    Lille Med; 1965 Apr; 10(4):431-6. PubMed ID: 5318637
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical trial with ethyl-a-p-chlorophenoxyisobutyrate (Atromid-S) with special reference to white blood cell counts.
    Engström J
    Acta Med Scand; 1966 Nov; 180(5):519-31. PubMed ID: 5332263
    [No Abstract]   [Full Text] [Related]  

  • 17. [The therapeutic use of CPIB in pathological increase of the lipid constituents of the blood].
    Cloarec M; Cottet J; Etienne J; Loeper J
    Sem Ther; 1965 Nov; 41(9):499-500. PubMed ID: 5877602
    [No Abstract]   [Full Text] [Related]  

  • 18. [Action of a 2.2 percent solution of androsterone, in chlorphenisate, on the serum lipoproteins of low density (LDL) in patients resistant to diet therapy].
    Bertolami V; Schneiderman B; Finatti AA; Netto RF
    Arq Bras Cardiol; 1966 Apr; 19(2):111-26. PubMed ID: 5943772
    [No Abstract]   [Full Text] [Related]  

  • 19. Divergent effects in the treatment of hyperlipemia.
    Slowe IA; Carter AC; Feldman EB
    Arch Intern Med; 1965 Oct; 116(4):523-30. PubMed ID: 5835355
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on lipemia in elderly persons and the lipid lowering effect of a clofibrate derivate in 2 groups of test persons].
    Rilliet B; Monnier J
    Praxis; 1969 Jun; 58(25):815-20. PubMed ID: 5819485
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.